Genetic mechanisms of hepatocarcinogenesis

Creative Commons License

Feitelson M., Sun B., Tufan N. L., Liu J., Pan J., Lian Z.

ONCOGENE, sa.16, ss.2593-2604, 2002 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Basım Tarihi: 2002
  • Doi Numarası: 10.1038/sj.onc.1205434
  • Dergi Adı: ONCOGENE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2593-2604
  • Anahtar Kelimeler: hepatocellular carcinoma, hepatitis viruses, loss of heterozygosity, mutations, HEPATITIS-B-VIRUS, HUMAN HEPATOCELLULAR-CARCINOMA, COMPARATIVE GENOMIC HYBRIDIZATION, IN-SITU HYBRIDIZATION, P53 TUMOR-SUPPRESSOR, GROWTH-FACTOR-BETA, ABERRANT DNA METHYLATION, E-CADHERIN GENE, NF-KAPPA-B, C VIRUS
  • Ankara Üniversitesi Adresli: Hayır

Özet

The development of hepatocellular carcinoma (HCC is a multistep process associated with changes in host gene expression, some of which correlate with the appearance and progression of tumor. Preneoplastic changes in gene expression result from altered DNA methylation, the actions of hepatitis B and C viruses, and point mutations or loss of heterozygosity (LOH) in selected cellular genes. Tumor progression is characterized by LOH involving tumor suppressor genes on many chromosomes and by gene amplification of selected oncogenes. The changes observed in different HCC nodules are often distinct, suggesting heterogeneity on the molecular level. These observations suggest that there are multiple, perhaps redundant negative growth regulatory pathways that protect cells against transformation. An understanding of the molecular pathogenesis of HCC may provide new markers for tumor staging, for assessment of the relative risk of tumor formation, and open new opportunities for therapeutic intervention.